Study Offers Support For Biosimilar-To-Biosimilar Switching

Practice Is Safe And Effective, But Not Covered By Current Regulations Or Guidance

 
• By David Wallace
  
Switch icon arrows blue
Biosimilar-to-biosimilar switching is examined in a new paper • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics